Neko Health, a full-body scan firm, receives $700 million to enter the US market

The startup, which works with Celebrities Claudia Schiffer, Maria Sharapova, Mark Zuckerberg, and Priscilla Chan, raised $700 million and will open a clinic in New York City later this year, but has yet to make an impact in the U.S. market.

Founded by former Spotify CEO and founder Daniel Ek and Hjalmar Nilsonne, the company provides non-invasive scans using radiation-free technology that it claims collects millions of data points related to health. Unlike its competitors, Prenuvo and Ezra (now owned by Function Health), Neko Health does not use large medical imaging machines such as MRIs for its scans.

Neko Health is collecting information about an individual’s skin, heart, blood, and metabolic wellness. The proprietary sensors, in conjunction with blood analysis, evaluate skin conditions, including moles and marks, as well as biomarkers that can indicate an increased risk of prediabetes, blood abnormalities, and metabolic syndrome, stroke, and heart attack. The client receives the results at their place and can consult with a medical professional to discuss the results face to face.

Neko’s health scans have been expanded to now support wearables integration and body composition analysis.

The scans cost £299 in U.K. currency or approximately $341 in U.S. dollars at the current exchange rate. However, the company did not specify the cost of the scans in the U.S. market.

The Series C round was co-led by Lightspeed Venture Partners and O.G. Venture Partners, with involvement by some existing partners, such as Atomico, General Catalyst and Lakestar, as well as new partners (Liberty City Ventures, Positive Sum, and BDT & MSD). David Ofer (O.G. Venture Partners) will be added to the board during the round time.

Other investors in the funding round included Ari Emanuel, Sir Matthew Vaughn, Danny Meyer, Jimmy Iovine, Thierry Henry, Tim Ferriss and will.i.am, as well as those already in the fold like Alexis Ohanian, of Seven Seven Six, Alex Tew and Michael Acton-Smith of Calm, Gary Vaynerchuk, Jessie Inchauspé, Katie Haun, Raj Shamani, Steven Bartlett, Zoë Saldaña and Marco Perego-Saldaña.

There’s a lot of confidence in what we set out to do three years ago when we opened our first clinic: a completely new healthcare experience that keeps people healthy, helps to identify problems early and prevent disease before it starts,” Nilsonne, whose company is CEO of Neko Health, said in a statement. This round, we are taking that mission to the U.S. for the first time, and we’re continuing to invest in the research and technology that makes prevention possible at scale — which is reflected in our members: The overwhelming majority of our members come back after their first scan, and when they return, their health markers go in the right direction.

Established in 2023, this company has practice offices in the U.K. (including several offices in London and Manchester, Birmingham) and Sweden. More than 350,000 people have been on a waitlist, or registered for a scan, and more than 100,000 have already had one, the company claims. Neko Health says 75% of members book and prepay for their scan for the coming year, on average, after their appointment.

Neko Health claims to develop its technology in-house, from hardware, software, and consumer experience. Executives say this allows them to manage the experience from end to end, to go faster, and to continually get better.

Last month, Neko opened its next-generation clinic in Stockholm, equipped with the new medical devices Neko has engineered, Derma-2, Echo-2, and Spectrum-2, which are designed to capture more and higher quality health signals from skin, heart, and circulation. This brand-new hardware will roll out at all Neko clinics in the coming months.

The company plans to use the funding to fuel its growth in the U.S. and invest in its technology.

“In the last 18 months, Neko Health has proven to be incredibly innovative and a rapidly growing company, tackling one of the largest markets in the world with breakthrough technology and consumer demand, and we are thrilled to further our partnership as they continue to redefine health prevention,” said Bejul Somaia, a global partner at Lightspeed Venture Partners.

The full-body scanning market is rapidly expanding as AI technology advances to speed up the scanning process, and is a growing elective, direct-to-consumer market. According to SNS Insider data, the market reached $29.7 billion in 2025 and will reach $47.2 billion by 2033.

The major companies in the market are Prenuvo, Ezra, which was merged with Function Health, and SimonMed. Prenuvo hit $120 million in 2025 and maintains 29 clinics, primarily in the United States, with three clinics located in Vancouver, Canada, London, and Melbourne, Australia.

In May 2025, Ezra was sold to a preventive health and longevity startup, Function Health, and will now be integrated with Function’s AI-powered full-body scans and testing capabilities. In November, the company raised $300 million in its 1st series B round.

Neko Health has raised $700 million to accelerate its expansion into the United States, marking a major milestone for the preventive healthcare company. Known for its advanced full-body scanning technology, Neko Health combines artificial intelligence, medical imaging, and comprehensive health assessments to identify potential health risks before symptoms develop.

The new funding will enable Neko Health to expand its operations, invest in research and development, and introduce its innovative health screening services to a broader population across the US.

Neko Health’s Vision for Preventive Healthcare

Founded with the goal of transforming preventive medicine, Neko Health focuses on detecting health issues at an early stage through non-invasive full-body scans. By integrating AI-driven diagnostics with advanced imaging technologies, Neko Health provides patients with detailed insights into their overall health in a single appointment.